Find clinical trials for Multiple Myeloma in Boston, MA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Boston, MA, USA:
if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple...
Phase 2
Boston, Massachusetts, United States and 2 other locations
This research study is evaluating a new drug called "ixazomib" as a possible treatment for Smoldering Multiple Myeloma....
Phase 2
Boston, Massachusetts, United States
pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma. The study drugs provided for research purposes are isa...
Phase 2
Boston, Massachusetts, United States and 1 other location
This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...
Phase 2
Boston, Massachusetts, United States and 5 other locations
of three drugs called lenalidomide, subcutaneous (injection under the skin) bortezomib, and dexamethasone (RVD) as a possible treatment for multiple...
Phase 2
Boston, Massachusetts, United States and 7 other locations
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...
Phase 1
Boston, Massachusetts, United States and 1 other location
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....
Phase 2
Boston, Massachusetts, United States and 56 other locations
and safety of bb2121 in participants with relapsed and refractory multiple myeloma (RRMM) (Cohort 1), in participants with RRMM who ...
Phase 2
Boston, Massachusetts, United States and 25 other locations
a registration, open-label phase 1 study of the combination of ibrutinib/lenalidomide:/dexamethasone in women and men with relapsed/refractory multiple...
Phase 1
Boston, Massachusetts, United States and 4 other locations
(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...
Phase 3
Boston, Massachusetts, United States and 145 other locations
Clinical trials
Research sites
Resources
Legal